Bora Pharmaceuticals Co., LTD.

About Bora Pharmaceuticals Co., LTD.

Bora Pharmaceuticals Co., LTD. engages in the research, development, production, marketing, sale, and distribution of pharmaceutical products worldwide. It manufactures and sells generic, brand, and over-the-counter (OTC) drugs. The company is involved in contract development and manufacturing; consumer healthcare and OTC; and prescription drugs businesses. It also provides clinical and commercial manufacturing services, including solvent manufacturing; solid and liquid dosage forms; extrusion spheronization; immediate and extended release; core, sugar-coated, and film-coated tablets; fixed-dose combination products; and granules, and liquids sachet/stick pack filling. In addition, the company offers pharmaceutical development services, such as liquid and solid dosage forms, and immediate and modified release, analytical method development and validation; packaging and serialization services, which include bottle and blister packaging, and sachets; and raw materials and finished products testing, and analytical techniques services, as well as method verification, validation, and transfer. Further, it provides OTC medicines, foods and vitamins supplements; and skincare products. Additionally, the company offers market analysis, drug and regulatory related services, price development, GDP warehousing, distribution, packaging, marketing planning, and sales services. The company's sales and distribution network comprising of medical centers, hospitals, clinics, pharmacies, drug stores, CVS, and specialty channels. Bora Pharmaceuticals Co., LTD. was incorporated in 2007 and is based in Taipei, Taiwan.

Bora Pharmaceuticals is a premier international pharmaceutical services company dedicated to contributing to better health all over the world.

https://www.bora-corp.com

6472.TWO Taiwan

328USD8 (+2.44%)

• At close Thu Oct 06 2022

Taipei Exchange exchange

Sector: Healthcare

Industry: Drug Manufacturers—Specialty & Generic

Location Taiwan, Taipei

Grade: ACF

1,988,785,048 USD
MARKET CAP
27.728
PE
0.774
BETA (5y)
29.140
EPS

Profits

for 5 years
1,728%
for 3 years
256%
for 2 years
126%
for last year
87%
for this year
0%
Bora Pharmaceuticals Co., LTD.
© 2023 avazzy.com. All rights reserved
Make with 🤎 and ☕ for you!

Investing involves risk, including possible loss of principal.

The strategies discussed are strictly for illustrative and educational purposes and are not a recommendation, offer or solicitation to buy or sell any securities or to adopt any investment strategy. There is no guarantee that any strategies discussed will be effective.

International investing involves risks, including risks related to foreign currency, limited liquidity, less government regulation and the possibility of substantial volatility due to adverse political, economic or other developments. These risks often are heightened for investments in emerging/ developing markets or in concentrations of single countries.